Brown-Forman (BFB) Q3 2025 earnings summary

Executive summary

• Year-to-date fiscal 2025 net sales decreased 4% to $3.1B, but increased 2% on an organic basis, reflecting divestitures, FX headwinds, and business model changes.

• Operating income declined 13% to $902M, while organic operating income grew 5%; diluted EPS fell 4% to $1.53, aided by a $78M gain on the Duckhorn investment sale.

• Major restructuring included a 12% global workforce reduction, executive team changes, and closure of the Louisville cooperage, incurring $33M in charges and expected to deliver $70–$80M in annualized savings.

• Divestitures of Finlandia and Sonoma-Cutrer were primary drivers of reported net sales declines but benefited gross margin in the latest quarter.

• Full-year organic net sales and operating income guidance reaffirmed, with expectations to achieve 2–4% growth despite ongoing uncertainties.

Financial highlights

• Net sales: $3.1B, down 4% year-over-year; organic net sales up 2%.

• Gross profit for nine months: $1.83B, down 6% year-over-year; gross margin contracted 150 bps to 59.4%.

• Operating income: $902M, down 13%; organic operating income up 5%.

• Diluted EPS: $1.53, down 4% year-over-year; $78M gain from Duckhorn investment sale.

• Operating expenses declined 8%, with advertising down 9% and SG&A down 7%.

Outlook and guidance

• Fiscal 2025 organic net sales and operating income growth expected in the 2–4% range, guided to the lower end for sales and upper end for income.

• Full-year gross margin expected to remain consistent with year-to-date levels; higher input costs, especially for tequila, to persist.

• Capital expenditures projected at $180–$190M; effective tax rate updated to 20–22%.

• Management anticipates continued volatility from macroeconomic and geopolitical factors.